Germany’s single-cell biotechnology sector is transforming cancer treatments by shining a light on the genetic activity of individual cells. It’s also advancing our understanding of how our immune defences respond to Covid-19.
Location / R&D
Wheel.Me from Oslo has designed what it says is the world’s first autonomous logistics wheel combining robotics, indoor navigation technology and data analytics. The scale-up has just taken this innovative idea to Germany, establishing a subsidiary near the logistics hub of Frankfurt.
A study in the journal Nature-Scientific Reports has shown that cold atmospheric plasmajet (CAP-jet) is far more salutary than the standard best-practice treatment of wounds.
Researchers at the Technical University of Munich (TUM) – together with colleagues Ludwig Maximilian University of Munich and German Research Center for Environmental Health Helmholtz Zentrum München – have made a discovery they say could be used to treat Covid-19 infections.
According to preliminary calculations by the Federal Statistical Office, Germany put EUR 105.9 billion into R&D in 2020, over three percent of the country’s gross domestic product.
Researchers at the Technical University of Chemnitz and Dresden’s Leibniz Institute IFW have constructed a battery the size of a dust particle. Scientists at the Changchun Institute of Applied Chemistry were also involved in the project, which is being touted as the world’s tiniest battery.
1400 degrees Celsius and 200 MPa – nearly enough heat to melt iron and the pressure of a luxury car resting on the point of a finger. Those are the impressive specs of the Hot Isostatic Press (HIPpe) at Bremen’s ECOMAT technology center.
One of the most promising areas in the fight against cancer is so-called CAR-T therapies. At its core are genetically engineered chimeric antigen receptor T cells that allow the immune system to specifically target cancer cells.
German rental car giant Sixt, for instance, is teaming up with American microprocessor colossus Intel and Israeli start-up Mobileye to launch a robotaxi service in Munich in 2022.
Researchers at Max Delbrück Centre for Molecular Medicine (MDC) in Berlin have identified rare gene variants that increase susceptibility to the skin disease eczema.